Case Study: Using Computational Modeling & Simulation (CM&S) to Improve Heart Valve Replacement
Updated: Jul 6
To download the full case study click here.
Over 5 million Americans, close to 2.5% globally, are diagnosed with heart valve disease each year. The Transcatheter Aortic Valve Implantation (TAVI) procedure has become fairly routine to treat heart valve disease. It means you would have an artificial valve implanted into your heart. TAVI is a more reliable and less complicated procedure than open-heart surgery.
In this procedure, they insert a stent in your femoral artery, that’s on the inner thigh, and the stent is transported to the heart where the new valve is inserted.
This procedure is growing in popularity and utility so it is important for clinicians and surgeons to have good procedural methods to handle different kinds of patient conditions. But complications can still arise: they can cause strokes, restricted blood flow, or leakage. the new valve has to fit perfectly otherwise it's no good. And that's the reason for FEops' challenge. They had to make sure that the procedure can work predictably for each unique patient.
FEops used Computational Modeling & Simulation (CM&S) to predict accurately how the valve will interact with each unique patient. Using ABAQUS explicit, and the power of the portfolio, FEops reduce simulation time from days to hours and helped accelerate their technology to market where it’s helping people live longer.
To learn more about CM&S in medical device development, sign up for a series of webinars produced by Aventec starting July 30th, 2020.